Life Sciences

  • January 30, 2024

    Troutman Pepper Gains McGuireWoods Securities Pros In NC

    Troutman Pepper is bolstering its Charlotte, North Carolina, corporate practice with two experienced securities attorneys who are making the leap from McGuireWoods LLP, the firm announced Tuesday.

  • January 30, 2024

    Guardant Diagnostics Patent Survives PTAB Challenge

    The Patent Trial and Appeal Board has refused to invalidate claims of a Guardant Health diagnostics patent, which had been challenged by TwinStrand Biosciences, finding the claims were not too obvious to get patent protection.

  • January 29, 2024

    CareDx Hit With $96M Infringement Verdict Over DNA Test IP

    A Delaware jury has moved to award Natera over $96 million in damages after finding that rival CareDx infringed one of its patents through the sale of its DNA tests for organ transplant recipients.

  • January 29, 2024

    Don't Keep Us Out Of ITC, Startup Says In Apple Watch Row

    A Silicon Valley medical device startup that wants the U.S. International Trade Commission to ban certain health-related features from being employed by new Apple Watches is arguing that this dispute is important to ensure that other startups that don't make products can litigate their grievances with tech giants at the Washington, D.C.-based commission.

  • January 29, 2024

    HHS Urges Court To Reject Novo Nordisk Drug Plan Challenge

    The U.S. Department of Health and Human Services is asking a New Jersey federal judge to reject the challenge diabetes care drugmaker Novo Nordisk Inc. has been mounting against an effort to establish a drug price negotiation program aiming to lower costs for Medicare's prescription drug plan.

  • January 29, 2024

    Hearing Aid Co. Eargo Investors Ask 9th Circ. To Revive Suit

    Investors of Eargo Inc. have told the Ninth Circuit that a lower court erred in dismissing their class action against the hearing aid company since they sufficiently alleged the firm and its top brass acted with intent to commit insurance billing fraud.

  • January 29, 2024

    Justices To Hear Abortion Drug Case Arguments In March

    The U.S. Supreme Court is set to consider live arguments in a case that could determine the future availability of a widely used abortion medication, advancing a matter some regard as the most significant battle over abortion since the justices overruled Roe v. Wade.

  • January 29, 2024

    The Top Attys In Clinton's Impeachment Trial, 25 Years Later

    One of them just went to federal prison, and another famously beat a federal indictment. One has been seeking the White House, and another has been steering a BigLaw powerhouse. Each was among the two dozen attorneys who litigated President Bill Clinton's historic impeachment trial 25 years ago this month — and then saw their lives go in dramatically different directions.

  • January 29, 2024

    Feds Drop Insider Trading Charges Against Ex-Mylan Exec

    Federal prosecutors in Pennsylvania dropped insider trading charges against a former executive of the since-merged pharmaceutical company Mylan just weeks before trial due to what defense attorneys said was flimsy evidence against their client.

  • January 29, 2024

    2 Biotech Firms Join IPO Fray With Plans To Raise $211M

    Two drug developers, metabolism-focused Fractyl Health Inc. and psychiatry-focused Alto NeuroScience Inc., joined a growing pipeline of initial public offerings Monday by unveiling plans for IPOs that could net $211 million combined, guided by three law firms.

  • January 29, 2024

    McCarter & English Urges Against Updating Malpractice Suit

    McCarter & English LLP has condemned a New Jersey biopharmaceutical company's latest attempt to amend its malpractice complaint against the firm, telling the court in a letter that some of the claims were time-barred or impossible to prove.

  • January 29, 2024

    Judge Might Screen Stimwave Ch. 11 Filings To Avoid 'Chaos'

    A Delaware bankruptcy judge said Monday that filings from the ex-CEO of Stimwave Technologies and two of her relatives had created "chaos" in the pain management device venture's Chapter 11 case and he was considering screening their motions.

  • January 29, 2024

    Imperative Care Names O'Melveny Deals Partner As CLO

    Silicon Valley's Imperative Care announced Monday that an O'Melveny deals partner will take over as chief legal officer, joining a revamped leadership team at the medical tech company.

  • January 29, 2024

    Catching Up With Delaware's Chancery Court

    A transportation services company and cryptocurrency fund both exited litigation, a grill maker and EV-charging company fired up new cases, and biotechs bandaged old wounds while judges fast-tracked a musical power struggle and unwound a REIT deal. All told, a typical week for Delaware's court of equity.

  • January 29, 2024

    White & Case Loses Another IP Partner To Cahill Gordon

    Another intellectual property partner has left White & Case LLP for Cahill Gordon & Reindel LLP, the firm said Monday, as Colleen Tracy James joins her former colleague Peter Armenio as co-chair of Cahill Gordon's life sciences patent litigation practice.

  • January 26, 2024

    GSK Unit Pauses Chancery Patent Suit For Settlement Talks

    A specialty pharma company majority-owned by GlaxoSmithKline has agreed to stay its Delaware Chancery Court lawsuit against a San Francisco biotech startup it accuses of butting into a university research collaboration and taking control of patents that the startup doesn't own.

  • January 26, 2024

    Generic-Drug Co. Concedes Infringement In Pfizer Heart Med Row

    An Israeli drugmaker trying to market a generic version of one of Pfizer's historically more expensive brands of heart medication has agreed to limit its legal fight with the U.S. pharmaceutical giant to whether Pfizer's patents covering the drug will hold up in Delaware federal court.

  • January 26, 2024

    Justices Urged To Bar Infringement Rulings After PTAB Ax

    A Patent Trial and Appeal Board decision that a patent is invalid should preclude an infringement finding in district court, Liquidia Technologies has told the U.S. Supreme Court, arguing that a contrary Federal Circuit decision "threatens to destabilize patent litigation."

  • January 26, 2024

    Dissolved Biomed Co. Aims To Bar Ex-CEO's Credit Bid In Del.

    A former officer of a biomedical company startup that was ordered dissolved by Delaware's chancellor for "egregious misconduct" by its founder and former CEO has asked the court to declare any purported debts to the ex-CEO to be unrecoverable gifts ineligible for use in bidding for the business.

  • January 26, 2024

    Tenn. Couple Sentenced For $65M Tricare Fraud

    A Tennessee couple was sentenced in California federal court for coordinating a scheme that cheated Tricare out of more than $65 million, according to a U.S. Department of Justice press release published Thursday.

  • January 26, 2024

    Chancery Hits Hedge Fund With Sanctions In Bioverativ Case

    An activist hedge fund principal and four affiliated funds were hit with hefty Delaware Chancery Court pretrial sanctions Friday for unexplained loss or deletion of electronic messages sought for a stockholder challenge to Sanofi's $11.6 billion acquisition of biomedical venture Bioverativ.

  • January 26, 2024

    2nd Circ. Backs Catholic Health System's Win In Bias Suit

    The Second Circuit refused to reinstate a psychiatrist's lawsuit alleging he was denied positions at a Catholic hospital system after raising concerns about its religious-based code of conduct for staff, saying he failed to show that his Russian Orthodox faith conflicted with the health system's principles.

  • February 08, 2024

    Law360 Seeks Members For Its 2024 Editorial Boards

    Law360 is looking for avid readers of its publications to serve as members of its 2024 editorial advisory boards.

  • January 26, 2024

    Panel Backs AG's Power To Nix Claims In $26B Opioid Deal 

    Pennsylvania's attorney general had the authority to join a $26 billion, multistate settlement with opioid companies and shut down consumer protection lawsuits brought by two district attorneys, a state appellate court ruled Friday, handing a first-impression defeat to local prosecutors challenging the attorney general's authority to release their claims in the blockbuster litigation.

  • January 26, 2024

    Ex-Goodwin Procter Life Sciences Atty Joins DLA Piper In NY

    DLA Piper announced it has hired an experienced life sciences transactional attorney from Goodwin Procter LLP as a New York-based partner in its corporate practice.

Expert Analysis

  • What's At Stake In Bystolic 'Side Deals' Litigation

    Author Photo

    In re: Bystolic Antitrust Litigation, which has oral argument set for next month, will likely shed light on how the U.S. Court of Appeals for the Second Circuit views side deals, and could create a circuit split in pleading standards for reverse payment cases, say attorneys at Axinn.

  • 2 HHS Warnings Highlight Anti-Kickback Risks For Physicians

    Author Photo

    Two recent advisory opinions issued by the U.S. Department of Health and Human Services' Office of Inspector General involve different scenarios and rationales, but together they illustrate the OIG's focus on and disapproval of contractual joint ventures and other revenue-maximizing physician arrangements, say Robert Threlkeld and Elliott Coward at Morris Manning.

  • Attorneys Have An Ethical Duty To Protect The Judiciary

    Author Photo

    The tenor of public disagreement and debate has become increasingly hostile against judges, and though the legislative branch is trying to ameliorate this safety gap, lawyers have a moral imperative and professional requirement to stand with judges in defusing attacks against them and their rulings, says Deborah Winokur at Cozen O'Connor.

  • Cross-Market Implications In FTC's Anesthesia Complaint

    Author Photo

    The Federal Trade Commission's recent complaint against a private equity firm's acquisition of anesthesiology practices highlights the controversial issue of cross-market harm in health care provider mergers, and could provide important insights into how a court may view such theories of harm, say Christopher Lau and Dina Older Aguilar at Cornerstone Research.

  • FTC Orange Book Move Signals New Pharma Patent Scrutiny

    Author Photo

    The Federal Trade Commission's recent dispute against improper listing of drug patents in the U.S. Food and Drug Administration's Orange Book indicates heightened surveillance of the pharmaceutical industry, particularly where competition-related consequences of patent or regulatory processes are concerned, say attorneys at Fenwick.

  • AI Can Help Lawyers Overcome The Programming Barrier

    Author Photo

    Legal professionals without programming expertise can use generative artificial intelligence to harness the power of automation and other technology solutions to streamline their work, without the steep learning curve traditionally associated with coding, says George Zalepa at Greenberg Traurig.

  • How Legal Teams Can Prep For Life Sciences' Tech Revolution

    Author Photo

    The life sciences and health care industries are uniquely positioned to take advantage of new efficiencies created by cloud computing and generative artificial intelligence, but the sensitivity of their data also demands careful navigation of an expanding legislative and regulatory landscape, say Kristi Gedid, Zack Laplante and Lisa LaMotta at Ernst & Young.

  • Preparing Law Students For A New, AI-Assisted Legal World

    Author Photo

    As artificial intelligence rapidly transforms the legal landscape, law schools must integrate technology and curricula that address AI’s innate challenges — from ethics to data security — to help students stay ahead of the curve, say Daniel Garrie at Law & Forensics, Ryan Abbott at JAMS and Karen Silverman at Cantellus Group.

  • Series

    ESG Around The World: South Korea

    Author Photo

    Numerous ESG trends have materialized in South Korea in the past three years, with impacts ranging from greenwashing prevention and carbon neutrality measures to workplace harassment and board diversity initiatives, say Chang Wook Min and Hyun Chan Jung at Jipyong.

  • General Counsel Need Data Literacy To Keep Up With AI

    Author Photo

    With the rise of accessible and powerful generative artificial intelligence solutions, it is imperative for general counsel to understand the use and application of data for myriad important activities, from evaluating the e-discovery process to monitoring compliance analytics and more, says Colin Levy at Malbek.

  • Trending At The PTAB: Administrative Procedure

    Author Photo

    A pair of recent Federal Circuit rulings on Patent Trial and Appeal Board inter partes review shed light on applications of the Administrative Procedure Act, adding to an ever-growing body of case law showing the board's final written decision must be based on arguments clearly put forth by the parties, say Robert High and Benjamin Saidman at Finnegan.

  • Rite Aid's Reasons For Ch. 11 Go Beyond Opioid Suits

    Author Photo

    Despite opioid-related lawsuits being the perceived reason that pushed Rite Aid into bankruptcy, the company's recent Chapter 11 filing reveals its tenuous position in the pharmaceutical retail market, and only time will tell whether bankruptcy will right-size the company, says Daniel Gielchinsky at DGIM Law.

  • Navigating Discovery Of Generative AI Information

    Author Photo

    As generative artificial intelligence tools become increasingly ubiquitous, companies must make sure to preserve generative AI data when there is reasonable expectation of litigation, and to include transcripts in litigation hold notices, as they may be relevant to discovery requests, say Nick Peterson and Corey Hauser at Wiley.

  • FDA's Lab-Developed Test Rule May Bring Historic Challenges

    Author Photo

    If finalized, the U.S. Food and Drug Administration's proposed rule for regulating laboratory-developed tests will provoke some of the most interesting legal challenges that the agency has faced in decades, with outcomes that will likely reverberate across the agency's product centers, says Stacy Amin at MoFo.

  • Finding Focus: Strategies For Attorneys With ADHD

    Author Photo

    Given the prevalence of ADHD among attorneys, it is imperative that the legal community gain a better understanding of how ADHD affects well-being, and that resources and strategies exist for attorneys with this disability to manage their symptoms and achieve success, say Casey Dixon at Dixon Life Coaching and Krista Larson at Stinson.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Life Sciences archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!